Literature DB >> 11121849

Reaching maturity - 25 years of the TDR.

C M Morel1.   

Abstract

In its first 25 years of existence, TDR has become a key player in the development of new tools for the control of tropical diseases and the training of researchers from disease-endemic countries. In order to maintain its leading position, cope with new health challenges and profit from new avenues opened by science and technology breakthroughs, a new strategic vision is now being implemented. It aims at a closer interaction with health systems and disease control programmes, capacity strengthening based on selected research initiatives and full exploitation of scientific and technological advances in the biomedical, social and information sciences, as discussed here by Carlos Morel.

Entities:  

Mesh:

Year:  2000        PMID: 11121849     DOI: 10.1016/s0169-4758(00)01815-9

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  12 in total

1.  Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships.

Authors:  Robert G Ridley
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 2.  Leprosy: steps along the journey of eradication.

Authors:  Brian H Bennett; David L Parker; Mark Robson
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

3.  Schistosoma mansoni infection: an immune complex disease presenting with polyarthritis.

Authors:  Aline Tamires Lapa; Simone Appenzeller; Manoel B Bértolo
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

4.  Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC 4785.

Authors:  Masahiko Isaka; Amonlaya Jaturapat; Jarin Kramyu; Morakot Tanticharoen; Yodhathai Thebtaranonth
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

5.  Surveillance of Schistosoma japonicum infection in domestic ruminants in the Dongting Lake region, Hunan province, China.

Authors:  Jinming Liu; Chunxia Zhu; Yaojun Shi; Hao Li; Lanpin Wang; Shangtian Qin; Saie Kang; Yanpin Huang; Yamei Jin; Jiaojiao Lin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

6.  Antimalarial Effects of Iranian Flora Artemisia sieberi on Plasmodium berghei In Vivo in Mice and Phytochemistry Analysis of Its Herbal Extracts.

Authors:  Hossein Nahrevanian; Bayram Sheykhkanlooye Milan; Masoud Kazemi; Reza Hajhosseini; Soudeh Soleymani Mashhadi; Shahab Nahrevanian
Journal:  Malar Res Treat       Date:  2012-01-23

7.  In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components.

Authors:  H Nahrevanian; B Esmaeili; M Kazemi; H Nazem; M Amini
Journal:  Iran J Parasitol       Date:  2010-03       Impact factor: 1.012

8.  Concomitant infections of Plasmodium falciparum and Wuchereria bancrofti on the Kenyan coast.

Authors:  Ephantus J Muturi; Charles M Mbogo; Joseph M Mwangangi; Zipporah W Ng'ang'a; Ephantus W Kabiru; Charles Mwandawiro; John C Beier
Journal:  Filaria J       Date:  2006-05-24

Review 9.  Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature.

Authors:  Julia L Finkelstein; Mark D Schleinitz; Hélène Carabin; Stephen T McGarvey
Journal:  PLoS Negl Trop Dis       Date:  2008-03-05

10.  Social research on neglected diseases of poverty: continuing and emerging themes.

Authors:  Lenore Manderson; Jens Aagaard-Hansen; Pascale Allotey; Margaret Gyapong; Johannes Sommerfeld
Journal:  PLoS Negl Trop Dis       Date:  2009-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.